<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03353012</url>
  </required_header>
  <id_info>
    <org_study_id>Sitanan Lertsiripanich</org_study_id>
    <nct_id>NCT03353012</nct_id>
  </id_info>
  <brief_title>Acceptability &amp; Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant</brief_title>
  <official_title>Acceptability &amp; Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study and compare acceptability and tolerance between breast-feeding post-partum woman,
      who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving
      birth, using either Levonorgestrel or Etonogestrel contraceptive implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  To study and compare acceptability and tolerance between breast-feeding post-partum
           woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks
           after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.

        -  Participants who wish to attend the study will be invited to choose between
           Levonorgestrel and Etonogestrel contraceptive implant, then they will be randomized into
           immediate postpartum or delay postpartum group. They will be follow-up at 6 and 12 weeks
           after receive contraceptive implant.

        -  Information about side effects, breastfeeding status, child growth, acceptability and
           tolerance will be noted using medical records and interviewing, gathering on paper case
           record forms.

        -  Sample size N = 60 (30 in each group (Immediate and delay postpartum group, 15 in each
           subgroup (Levonogestrel and Etonogestrel group)) This number of sample size is already
           counted with 10% data loss
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with treatment-related adverse events</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare treatment-related adverse events between Immediate and delayed breastfeeding postpartum contraceptive users, using case record form which specify bleeding days, spotting days, abdominal discomfort, headache, acne, alopecia, weight and blood pressure of users.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Removal rate of contraceptive implants users</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare tolerance between Immediate and delayed breastfeeding postpartum contraceptive users, by collecting and calculating removal rate of users.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfactory of contraceptive implant users</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare acceptability between Immediate and delayed breastfeeding postpartum contraceptive users, using questionnaire rating satisfactory scale by score from 1 to 5</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Breastfeeding status</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare breastfeeding status between Immediate and delayed breastfeeding postpartum contraceptive users by using questionnaire whether each participant is full-breastfeeding, partial-breastfeeding or non-breastfeeding and specify reasons if she's not full-breastfeeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child weight</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare child growth by measuring weight, between Immediate and delayed breastfeeding postpartum contraceptive users.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child height</measure>
    <time_frame>immediately after contraceptive implant use until 12 weeks after use</time_frame>
    <description>To compare child growth by measuring height, between Immediate and delayed breastfeeding postpartum contraceptive users.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Breastfeeding</condition>
  <condition>Post Partum</condition>
  <arm_group>
    <arm_group_label>Levonorgestrel immediate post-partum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breast-feeding postpartum woman who receive Levonorgestrel drug implant (75 mg) between 48-72 hr after child delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Etonogestrel immediate post-partum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breast-feeding postpartum woman who receive Etonogestrel drug implant (68 mg) between 48-72 hr after child delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levonorgestrel delayed post-partum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breast-feeding postpartum woman who receive Levonorgestrel drug implant (75 mg) between 5-7 weeks after child delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Etonogestrel delayed post-partum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breast-feeding postpartum woman who receive Etonogestrel drug implant (68 mg) between 5-7 weeks after child delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etonogestrel Drug Implant</intervention_name>
    <description>Etonogestrel 68 mg (single rod) is implanted at inner arm of participant.</description>
    <arm_group_label>Etonogestrel immediate post-partum</arm_group_label>
    <arm_group_label>Etonogestrel delayed post-partum</arm_group_label>
    <other_name>Implanon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levonorgestrel Drug Implant</intervention_name>
    <description>Levonorgestrel 75 mg (2 rods) are implanted at inner arm of participant.</description>
    <arm_group_label>Levonorgestrel immediate post-partum</arm_group_label>
    <arm_group_label>Levonorgestrel delayed post-partum</arm_group_label>
    <other_name>Jadelle</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Breast-feeding post-partum woman aged 18-45 years who wish to use contraceptive
             implant

        Exclusion Criteria:

          -  Pregnant

          -  Woman who has any medical conditions which is considered contraindicated to use
             contraceptive implant

          -  Woman with severe antepartum or peripartum complications

          -  Woman who is contraindicated to breastfeed.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Unnop Jaisamrarn, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sitanan Lertsiripanich, M.D.</last_name>
    <phone>0829727222</phone>
    <email>fernie@docchula.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Pathum Wan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sitanan Lertsiripanich, M.D.</last_name>
      <phone>0829727222</phone>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immediate postpartum implant</keyword>
  <keyword>postpartum implant</keyword>
  <keyword>implant contraception</keyword>
  <keyword>Etonogestrel</keyword>
  <keyword>Levonorgestrel</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Levonorgestrel</mesh_term>
    <mesh_term>Etonogestrel</mesh_term>
    <mesh_term>Desogestrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

